SMi’s 3rd Annual Pharmaceutical Microbiology West Coast Conference

Bolstering Strategies to Maintain Contamination Control

Conference: 5 – 6 June 2019
Workshops: 4 June 2019

Location: Hyatt Regency Mission Bay Hotel, San Diego, CA, USA

Website: http://www.pharma-microbiology-usa.com/pharmaphorum

SPONSORED BY: Associates of Cape Cod, bioMérieux, Bioscience International, Charles River, DuPont, FujiFilm and Microbiologics

CHAIRED BY: Ziva Abraham, CEO, Microrite

SMi proudly presents the 3rd Annual Pharmaceutical Microbiology West Coast Conference, in San Diego, USA, on the 5th and 6th of June 2019.

The pharmaceutical microbiology field is an ever-present constant in almost all areas of pharmaceuticals. We are experiencing a period of rapid change, with new regulatory considerations to implement into our environmental monitoring programmes, new technologies to improve processes and novel validation techniques.

Join us as we delve into the current evolving issues facing this industry, such as: risk-based approaches to aseptic processing, methods of contamination prevention, creating risk-based environmental monitoring programmes, water monitoring and treatment.

Event Hashtag: #SMiPharmaMicroWC

Highlights in 2019 include:

Discuss how to overcome challenges following RMM implementation
Hear the developments in creating an effective contamination control strategy
Evaluate novel methods for endotoxin testing
Explore strategies to create effective EM programmes to ensure compliance
Investigate a case of sterility failure and determine the entry point of contamination

KEY SPEAKERS INCLUDE:

Irving Ford, Head of CAR T QC Laboratories, Celgene
Chris Knutsen, Associate Director, Microbiology, Bristol Myers Squibb
Friedrich von Wintzingerode, Senior Manager gASAT Microbiology, Global QC, Genentech
Ren-Yo Forng, Scientific Director, Amgen
Anita Bawa, Director of Quality Control, Bayer
Lucia Clontz, Quality Director, Xellia Pharmaceuticals

KEY TOPICS FOR 2018 INCLUDE:

Contamination Control and Microbial, Identification
Endotoxin Testing and LER
Environmental Monitoring and Rapid Microbial Methods
Contamination Control considerations for special Drug Products

Plus 2 half day interactive workshops on Tuesday, June 4th 2019:

Workshop A: Assessing a Holisitic Approach to Microbial Contamination Control
Led by: Ziva Abraham, CEO, Microrite

Workshop B: Reviewing the Road Map to a Holistic Approach to Microbial Impurities, Endotoxins and LER.
Led by: Friedrich von Wintzingerode, Senior Manager gASAT Microbiology, Global QC, Genentech & Farnaz Nowroozi, Scientist and Manager, Genentech

View the full agenda: http://www.pharma-microbiology-usa.com/pharmaphorum

WHO SHOULD ATTEND

Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist Drug Substance External Manufacturer, Business Development Manager – Testing, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist, Analytical Standards Specialist

EARLY BIRD-RATES